Infectious Diseases (except HIV/AIDS)
-
Highly Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe PCR
This article has 28 authors:Reviewed by ScreenIT
-
Automated interpretable discovery of heterogeneous treatment effectiveness: A COVID-19 case study
This article has 5 authors:Reviewed by ScreenIT
-
Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-Plus: a double-blind, randomised, placebo-controlled phase 3 clinical trial
This article has 34 authors:Reviewed by ScreenIT
-
Homologous and Heterologous Anti-COVID-19 Vaccination Does Not Induce New-Onset Formation of Autoantibodies Typically Accompanying Lupus Erythematodes, Rheumatoid Arthritis, Celiac Disease and Antiphospholipid Syndrome
This article has 8 authors:Reviewed by ScreenIT
-
Label-Free Spectroscopic SARS-CoV-2 Detection on Versatile Nanoimprinted Substrates
This article has 6 authors:Reviewed by ScreenIT
-
Comparison of the immunogenicity of BNT162b2 and CoronaVac COVID ‐19 vaccines in Hong Kong
This article has 19 authors:Reviewed by ScreenIT
-
Feasibility and lessons learned on remote trial implementation from TestBoston, a fully remote, longitudinal, large-scale COVID-19 surveillance study
This article has 18 authors:Reviewed by ScreenIT
-
Multiethnic Investigation of Risk and Immune Determinants of COVID-19 Outcomes
This article has 8 authors:Reviewed by ScreenIT
-
Vaccination of COVID ‐19 convalescent plasma donors increases binding and neutralizing antibodies against SARS‐CoV ‐2 variants
This article has 7 authors:Reviewed by ScreenIT
-
Vaccine-induced humoral response against SARS-CoV-2 dramatically declined but cellular immunity possibly remained at 6 months post BNT162b2 vaccination
This article has 10 authors:Reviewed by ScreenIT